Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Inclusion Criteria (Selection): * Provide written informed consent, approved by the appropriate ethics committee; * Able to comply with the study requirements and visit schedule; * At least 18 years of age of either sex or any race; * Will undergo unilateral cataract extraction via phacoemulsification and PCIOL implantation in the study eye; * Have an anterior chamber cell score ≥ 2 at Visit 2 (Day 1 \[18 to 30 hours post- uncomplicated cataract surgery without vitreous loss\]); Exclusion Criteria: * Have a known sensitivity or allergy to dexamethasone, corticosteroids, or any of the study medication's components; * Have only one functional eye (monocular); * Have any intraocular inflammation (e.g., white blood cells or flare) present in either eye at the Visit 1 (Day -1 to Day -28 \[prior to surgery\]) slit-lamp examination; * Have a score \> 0 on the Ocular Pain Assessment at Visit 1 (Day -1 to Day -28 \[prior to surgery\]) in the study eye \*Additional inclusion/exclusion criteria apply